| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/13/2007 | US20070213398 Inhibitors of phosphatidyl myo-inositol cycle |
| 09/13/2007 | US20070213397 Motuporamine mimic agents |
| 09/13/2007 | US20070213395 Dietary supplement composition for blood lipid health |
| 09/13/2007 | US20070213394 Salvinorin derivatives and uses thereof |
| 09/13/2007 | US20070213393 Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents |
| 09/13/2007 | US20070213392 Thiophene and Benzothiophene Hydroxamic Acid Derivatives |
| 09/13/2007 | US20070213391 Furosemide modulators of hm74 |
| 09/13/2007 | US20070213390 HMGCoA reductase inhibitor-angiotensin converting enzyme inhibitor compounds |
| 09/13/2007 | US20070213389 Process and substances for the release of a growth-regulating factor from endothelial cells |
| 09/13/2007 | US20070213388 Acetylcholinesterase Inhibitors and N-Methyl-D-Aspartate Antagonists Useful in the Treatment of of Cognitive Disorders |
| 09/13/2007 | US20070213387 Such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; protein kinase C inhibitors; for treatment of diabetes |
| 09/13/2007 | US20070213386 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, used for treating diabetes, dementias such as Alzheimer's disease and bipolar disorders |
| 09/13/2007 | US20070213385 New derivatives of 4,5,6,7-tetrabromobenzimidazole and method of their preparation |
| 09/13/2007 | US20070213384 4-Amino-1,5-substituted-1,5-dihydro-imidazol-2-ones |
| 09/13/2007 | US20070213383 Sulfamic acid ester compounds useful in the inhibition of steroid sulphatase activity and aromatase activity |
| 09/13/2007 | US20070213382 2-methylthiazolidine-2, 4-dicarboxylic acid-containing combination preparations |
| 09/13/2007 | US20070213381 Topical Compositions Comprising Telmesteine for Treating Dermatological Disorders |
| 09/13/2007 | US20070213380 Thiadiazoline derivative |
| 09/13/2007 | US20070213379 Malonamides and malonamide derivatives as modulators of chemokine receptor activity |
| 09/13/2007 | US20070213378 Compounds for modulating cell proliferation, compositions and methods related thereto |
| 09/13/2007 | US20070213377 2-{4-[Ethyl-(thiazol-4-ylmethyl)-amino]-phenyl}-1,1,1,3,3,3-hexafluoro-propan-2-ol; liver-X-receptor modulators; anticholesterol agents; antiinflammatory agents; atherosclerosis; dyslipidemia; antidiabetic agents; alzheimer's disease; sepsis; skin disorders; cognition modulators |
| 09/13/2007 | US20070213376 Halogenated sulfonamide derivatives |
| 09/13/2007 | US20070213375 Triazole derivatives useful as Axl inhibitors |
| 09/13/2007 | US20070213374 Malonamide Derivatives |
| 09/13/2007 | US20070213373 Indazole derivatives as CRF antagonists |
| 09/13/2007 | US20070213372 Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands |
| 09/13/2007 | US20070213371 Dibenzyl Amine Compounds and Derivatives |
| 09/13/2007 | US20070213370 5-HTP Combination Therapy |
| 09/13/2007 | US20070213369 Novel non-psychotropic cannabinoids |
| 09/13/2007 | US20070213368 N-ethyl hydroxyethylamine useful in treating cns conditions |
| 09/13/2007 | US20070213367 Substituted 3-cyanoquinolines as MEK inhibitors |
| 09/13/2007 | US20070213366 Treatment of Synucleinopathies |
| 09/13/2007 | US20070213365 Novel polymorphs of montelukast ammonium salts and processes for preparation therefor |
| 09/13/2007 | US20070213364 Alkoxyphenylpropanoic Acid Derivatives |
| 09/13/2007 | US20070213363 Tetrahydro-Quinolinylurea Derivatives |
| 09/13/2007 | US20070213362 2-nh-heteroarylimidazoles with antibacterial activity |
| 09/13/2007 | US20070213361 Preventive and/or therapeutic agent for neutrophilic inflammatory diseases |
| 09/13/2007 | US20070213360 Tetrahydropyridothiophenes for Use in the Treatment of Cancer |
| 09/13/2007 | US20070213359 Bicyclic-nitrogen compounds as modulators of ghrelin receptor and uses thereof |
| 09/13/2007 | US20070213358 1-(4-chlorobenzyl)-7-(1,2,3,4-tetrahydroisoquinolin-2-yl)-2,3-dimethyl-1H-pyrrolo[3,2-b]pyridine hydrochloride; proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect; inhibitory activity against gastric acid secretion |
| 09/13/2007 | US20070213357 Use of Glucosidase Inhibitors for Therapy of Mucovisidosis |
| 09/13/2007 | US20070213356 Nitrogen-Containing Heterocyclyl Substituted Imidazoquinolines and Imidazonaphthyridines |
| 09/13/2007 | US20070213355 1H-Imidazo[4,5-C]Quinoline Derivatives in the Treatment of Protein Kinase Dependent Diseases |
| 09/13/2007 | US20070213354 Compositions and Methods for the Treatment of Multiple Sclerosis |
| 09/13/2007 | US20070213353 Esters in position 20 of camptothecins |
| 09/13/2007 | US20070213352 Pyridine-containing macroheterococylic compounds as kinase inhibitors |
| 09/13/2007 | US20070213351 Spirocyclic cyclohexane compounds |
| 09/13/2007 | US20070213350 Method of treating ileus by pharmacological activation of cholinergic receptors |
| 09/13/2007 | US20070213349 Glucokinase activators |
| 09/13/2007 | US20070213348 Chemical Compounds |
| 09/13/2007 | US20070213347 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction |
| 09/13/2007 | US20070213346 Substituted 4-Alkyl-And 4-Alkanoyl-Piperidine Derivatives And Their Use As Neurokinin Antagonists |
| 09/13/2007 | US20070213345 Immuno Inhibitory Pyrazolone Compounds |
| 09/13/2007 | US20070213344 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 09/13/2007 | US20070213343 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 09/13/2007 | US20070213342 2-1-Aza-bicyclo[2.2.2]oct-3-yl-6-phenyl-2,3-dihydro-isoindol-1-one, salts and radioactive materials for drug screening; anxiolytic agents; antidepressants; schizophrenia; cognitive activators; attention disorders; Alzheimer's disease; Parkinson's disease; Tourette's syndrome; neuroprotants; analgesics |
| 09/13/2007 | US20070213341 Spiroindolinone derivatives |
| 09/13/2007 | US20070213340 Farnesyl protein transferase inhibitors |
| 09/13/2007 | US20070213339 Quinolone Carboxylic Acid Derivatives for Treatment of Hyperproliferative Conditions |
| 09/13/2007 | US20070213338 Triazolo-Pyridazine Compounds and Derivatives Thereof Useful in the Treatment of Neuropathic Pain |
| 09/13/2007 | US20070213337 Modulators of serotonin receptors |
| 09/13/2007 | US20070213336 peroxisome proliferator activated receptor agonists, such as (E)-3-[3'-(3-heptyl-1-methylureido)biphenyl-4-yl]acrylic acid, useful in human or veterinary medicine (in dermatology, cardiovascular diseases, immune diseases and/or metabolism of lipids); cosmetics |
| 09/13/2007 | US20070213335 Prolyl Hydroxylase Inhibitors |
| 09/13/2007 | US20070213334 Cannabinoid receptor ligands and uses thereof |
| 09/13/2007 | US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 09/13/2007 | US20070213332 Prodrugs Of Substituted Amino Heterobicycles Which Modulate The Function Of The Vanilloid-1 Receptor (Vr1) |
| 09/13/2007 | US20070213331 Beta -secretase (BACE); Alzheimer's disease; 2-(R)-[2-(S)-Amino-3-(3,5-difluorophenyl)-1-(S)-hydroxypropyl]-pyrrolidine-1-carboxylic acid tert-butyl ester |
| 09/13/2007 | US20070213330 Anticancer agents; antiproliferative agents |
| 09/13/2007 | US20070213329 Sulphones which modulate the action of gammasecretase |
| 09/13/2007 | US20070213328 Pyridothiophene Compounds |
| 09/13/2007 | US20070213327 Inhibitors of Src family protein kinases; autoimmune, inflammatory, proliferative, or hyperproliferative, immunologically-mediated disease, or bone disease; 1-Cyclopentyl-3-(4-phenoxyphenyl)-1H-pyrrolo[3,2-c]pyridin-4-amine |
| 09/13/2007 | US20070213326 Substituted indole compounds and their use as 5-ht6 receptor modulators |
| 09/13/2007 | US20070213325 Multi-cyclic compound and method of use |
| 09/13/2007 | US20070213324 Stable pharmaceutical composition of carisoprodol and meloxicam |
| 09/13/2007 | US20070213323 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 09/13/2007 | US20070213322 Use |
| 09/13/2007 | US20070213321 Compounds for modulating TRPV3 function |
| 09/13/2007 | US20070213320 4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones |
| 09/13/2007 | US20070213319 Inflammatory diseases and dysproliferative diseases such as rheumatoid arthritis, cancer; N2-(2-(phenylthiobenzyl)-2,4-diamino-quinazolines |
| 09/13/2007 | US20070213318 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| 09/13/2007 | US20070213317 Inhibitors of the Mutant Form of Kit |
| 09/13/2007 | US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/13/2007 | US20070213315 Modulators of muscarinic receptors |
| 09/13/2007 | US20070213314 Dibenzyl Amine Compounds and Derivatives |
| 09/13/2007 | US20070213313 Direct process for the production of an amino acid dihydrochloride |
| 09/13/2007 | US20070213312 Hif-1 Inhibitors and Methods of Use Thereof |
| 09/13/2007 | US20070213311 Modulators of 11-beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same |
| 09/13/2007 | US20070213310 Prodrugs for Use as Ophthalmic Agents |
| 09/13/2007 | US20070213309 Sepsis Treatment Methods |
| 09/13/2007 | US20070213308 Methods, compositions, and kits for the treatment of musculoskeletal disorders and symptoms associated therewith |
| 09/13/2007 | US20070213307 Methods to treat autoimmune and inflammatory conditions |
| 09/13/2007 | US20070213306 Methods, dosing regimens & medications using anti-progestational agents for the treatment of disorders |
| 09/13/2007 | US20070213305 N-alkyl-N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/13/2007 | US20070213304 Use of Aminosalicylates in Diarrhoea-Predominent Irritable Bowel Syndrome |
| 09/13/2007 | US20070213303 Methods for reducing platelet activation and for the treatment of thrombotic events |
| 09/13/2007 | US20070213302 pyrazoles; diabetes, cardiometabolic disorders; side effects reduction |
| 09/13/2007 | US20070213301 Substituted Aminothiazole Derivatives With Anti-HCV Activity |
| 09/13/2007 | US20070213300 Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors |
| 09/13/2007 | US20070213299 pyridinium salts such as 1-ethyl-(E,E)-2,6-bis[2-[4-(dimethylamino)phenyl]ethenyl]pyridinium chloride, used as fungicides, bactericides or insecticides on a substrate ( lumber, decking, flooring, roofing, carpets, wallpaper, paneling, cloth caulking etc.); encapsulated, sustained release |
| 09/13/2007 | US20070213298 Omega 3 |